Inke | Jotup

Inkeverse Announces 2023 Annual Results

Retrieved on:

Tuesday, March 26, 2024

Inke, Growth, Artificial intelligence, RMB, Ecosystem, Networking hardware, Retail

HONG KONG, Mar 26, 2024 - (ACN Newswire) - Inkeverse Group Limited ("Inkeverse" or "the Group", stock code: 3700) has announced its annual results for the year ended December 31, 2023 (the "Reporting Period").

Key Points:

HONG KONG, Mar 26, 2024 - (ACN Newswire) - Inkeverse Group Limited ("Inkeverse" or "the Group", stock code: 3700) has announced its annual results for the year ended December 31, 2023 (the "Reporting Period").
Live streaming and social networking businesses remain steady, with platform advantage expanding
In 2023, Inkeverse maintained a healthy momentum in its live streaming and social networking businesses through refined operational strategies.
The flagship product "Inke App" improved the commercial monetization capabilities by optimizing resource management and incentive policies.
The platform advantage accumulated over the years in the live streaming field has effectively supported the Group's strategic multi-product plan.

Inkeverse 2022 Interim Results Announcement

Retrieved on:

Monday, August 29, 2022

HONG KONG, Aug 29, 2022 - (ACN Newswire) - Inkeverse Group Limited ("Inkeverse" or the "Group"; stock code: 3700.HK) has announced its interim results for the six months ended 30 June 2022 (the "Reporting Period").

Key Points:

HONG KONG, Aug 29, 2022 - (ACN Newswire) - Inkeverse Group Limited ("Inkeverse" or the "Group"; stock code: 3700.HK) has announced its interim results for the six months ended 30 June 2022 (the "Reporting Period").
In June 2022, we upgraded our brand, changing its name to Inkeverse Group Limited, and announcing our entry into the metaverse market.
In May 2022, the Group launched "Love Planet" for lovers to create a new ecology for romantic social networking.
Reflecting this shift, in 2022, Inke changed its name to Inkeverse, aiming to create a multidimensional social matrix combining reality and virtual reality based on a new technology model.

Inke Changed Its Name Into Inkeverse, to Comprehensively Embrace the web3.0

Retrieved on:

Monday, June 20, 2022

Recently, Inke (3700.HK) declared that its brand and strategic direction were comprehensively upgraded, changed its name into Inkeverse, and marched toward metaverse in its business.

Key Points:

Recently, Inke (3700.HK) declared that its brand and strategic direction were comprehensively upgraded, changed its name into Inkeverse, and marched toward metaverse in its business.
Inke it has been successfully transformed into a company promoting performance growth with matrix products from that with single product.
Inkeverse has introduced the layout of metaverse, including the immersive KTV function of Inke live streaming Panoramic Karaoke, Loverse.
In the past web2.0 era, Inke had a series of product matrixes, and our team has accumulated rich experience.

Leading inhalation APIs expert Inke to triple production capacity

Retrieved on:

Wednesday, April 20, 2022

BARCELONA, Spain, April 20, 2022 /PRNewswire/ -- Inke, a leading global manufacturer of inhalation APIs wholly owned by Neuraxpharm Group, announces it is investing €9 million to increase production capacity for inhalation APIs. The investment will allow Inke to triple the production capacity of chemical synthesis and the micronisation of inhalation APIs at its manufacturing plant in Castellbisbal, Barcelona, by 2024. The company expects that approximately 80% of this €9 million investment will be deployed by the end of this year.

Key Points:

BARCELONA, Spain, April 20, 2022 /PRNewswire/ --Inke, a leading global manufacturer of inhalation APIs wholly owned by Neuraxpharm Group, announces it is investing 9 million to increase production capacity for inhalation APIs.
The investment will allow Inke to triple the production capacity of chemical synthesis and the micronisation of inhalation APIs at its manufacturing plant in Castellbisbal, Barcelona, by 2024.
Its specialised capabilities, with over 20 years of in-house experience in micronisation and particle engineering to find the right crystal shape and particle size, make Inke an expert in the development of APIs.
Inke is a leading global manufacturer of inhalation active pharmaceutical ingredients (APIs) established in 1980 and based in Castellbisbal (Barcelona, Spain).

Leading inhalation APIs expert Inke to triple production capacity

Retrieved on:

Wednesday, April 20, 2022

BARCELONA, Spain, April 20, 2022 /PRNewswire/ -- Inke, a leading global manufacturer of inhalation APIs wholly owned by Neuraxpharm Group, announces it is investing €9 million to increase production capacity for inhalation APIs. The investment will allow Inke to triple the production capacity of chemical synthesis and the micronisation of inhalation APIs at its manufacturing plant in Castellbisbal, Barcelona, by 2024. The company expects that approximately 80% of this €9 million investment will be deployed by the end of this year.

Key Points:

BARCELONA, Spain, April 20, 2022 /PRNewswire/ --Inke, a leading global manufacturer of inhalation APIs wholly owned by Neuraxpharm Group, announces it is investing 9 million to increase production capacity for inhalation APIs.
The investment will allow Inke to triple the production capacity of chemical synthesis and the micronisation of inhalation APIs at its manufacturing plant in Castellbisbal, Barcelona, by 2024.
Its specialised capabilities, with over 20 years of in-house experience in micronisation and particle engineering to find the right crystal shape and particle size, make Inke an expert in the development of APIs.
Inke is a leading global manufacturer of inhalation active pharmaceutical ingredients (APIs) established in 1980 and based in Castellbisbal (Barcelona, Spain).